Cytogenix (fka CYGX)

[Houndish]

Stock Options

From the 10-K:
We have outstanding 124,460,970 shares of common stock as of December 31, 2005 and all are or will be after the date of issuance eligible for sale under Rule 144 or are otherwise freely tradeable.

Our employees have been granted options to buy a total of 35,004,000 shares of common stock as of December 31, 2005. The options granted have exercise prices between $.185 to $1.01 per share. The issuance of the shares of common stock to be issued upon exercise of these options, has not been registered as December 31, 2005

We may issue options to purchase up to an additional 996,000 shares of common stock at December 31, 2005 under our stock option plans.

124,460,970 + 35,004,000 + 996,000 = 160,460,970 Fully Diluted Shares Outstanding

At $1.00 a share that's 160.4 million fully diluted market cap on a company worth $407,521... eh hem... well we certaintly aren't undervalued... lol